Agreed. This is VERY positive news. If you are u
Post# of 145414
![](/assets/46931549/no_avatar_available_thumb.jpg)
1) We are requesting EUA in several countries including our own.
2) If we have to do a phase 3, it will be small and will enroll quickly.
3) CD12 Interim results are 45-60 days out and I believe is a show in for EUA approval.
4) No other drug has shown any efficacy in the M2M group.
5) M2M is likely the most difficult group to show efficacy in. S/C will be a slam dunk.
6) CYDY is getting ready to launch more trials, and is bringing in experts in various fields to assist.
7) Uplisting is progressing. Audited financials complete this week.
![8) 8)](smileys/bigeyes.gif)
I couldnt be happier with how thing are progressing.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)